Latest Breaking News On - Neuromyelitis opticaspectrum disorder - Page 1 : comparemela.com

/PRNewswire/ IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative.

Neuromyelitis opticaEquecabtagene autoleucelOwen wangChina national medical products administrationNational medical products administrationDrug administrationNeuromyelitis optica spectrum disorderInvestigator initiated trialExpanded disability status scaleChief executive officerChief medical officerNeuromyelitis opticaspectrum disorderOptica spectrum disorderDrug evaluationIaso biotherapeutics